Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 124, Issue -, Pages 125-139Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2017.08.010
Keywords
Mucus; Mucus barrier; PEG; Nanoparticle; Mucus-penetrating; Muco-inert; Diffusivity
Categories
Funding
- National Science Foundation Graduate Research Fellowship Program [DGE-1650116]
- National Science Foundation CAREER Award [DMR-1151477]
- David and Lucile Packard Foundation [2013-39274]
- Eshelman Institute for Innovation
- UNC Research Opportunities Initiative grant in Pharmacoengineering
Ask authors/readers for more resources
The viscoelastic mucus secretions coating exposed organs such as the lung airways and the female reproductive tract can trap and quickly eliminate not only foreign pathogens and ultrafine particles but also particle-based drug delivery systems, thus limiting sustained and targeted drug delivery at mucosal surfaces. To improve particle distribution across the mucosa and enhance delivery to the underlying epithelium, many investigators have sought to develop nanoparticles capable of readily traversing mucus. The first synthetic nanoparticles shown capable of rapidly penetrating physiological mucus secretions utilized a dense coating of polyethylene glycol (PEG) covalently grafted onto the surface of preformed polymeric nanoparticles. In the decade since, PEG has become the gold standard in engineering mucus-penetrating drug carriers for sustained and targeted drug delivery to the lungs, gastrointestinal tract, eyes, and female reproductive tract. This review summarizes the history of the development of various PEG-based mucus-penetrating particles, and highlights the key physicochemical properties of PEG coatings and PEGylation strategies to achieve muco-inert PEG coatings on nanoparticle drug carriers for improved drug and gene delivery at mucosal surfaces. (C) 2017 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available